Therefore, methods to increase p53 acetylation at lysine 320, either by inhibiting HDAC1 or HDAC6 deacetylases or by increasing PCAF activity, or a combination of these measures, may be therapeutically beneficial for post-stroke recovery [87]. This evidence concerns the gene TP53 and Stroke.